{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:45:41Z","timestamp":1774406741440,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["BSC0121"],"award-info":[{"award-number":["BSC0121"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["31\/56(0006)\/2014-EMR-I"],"award-info":[{"award-number":["31\/56(0006)\/2014-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007679","name":"Open Source Drug Discovery","doi-asserted-by":"publisher","award":["HCP0001"],"award-info":[{"award-number":["HCP0001"]}],"id":[{"id":"10.13039\/501100007679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006222","name":"United States - India Educational Foundation","doi-asserted-by":"publisher","award":["15151380"],"award-info":[{"award-number":["15151380"]}],"id":[{"id":"10.13039\/100006222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13321-018-0276-9","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T07:29:27Z","timestamp":1526887767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["RepTB: a gene ontology based drug repurposing approach for tuberculosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Anurag","family":"Passi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj Kumar","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshu","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"issue":"3","key":"276_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/trstmh\/trw006","volume":"110","author":"J Manjelievskaia","year":"2016","unstructured":"Manjelievskaia J, Erck D, Piracha S, Schrager L (2016) Drug-resistant TB: deadly, costly and in need of a vaccine. Trans R Soc Trop Med Hyg 110(3):186\u2013191","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"276_CR2","volume-title":"Global tuberculosis report 2016","author":"WHO","year":"2016","unstructured":"WHO (2016) Global tuberculosis report 2016. World Health Organization, Geneva"},{"issue":"3","key":"276_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S2213-2600(16)30423-4","volume":"5","author":"EA Kendall","year":"2016","unstructured":"Kendall EA, Fojo AT, Dowdy DW (2016) Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis. Lancet Respir Med 5(3):191\u2013199","journal-title":"Lancet Respir Med"},{"issue":"1","key":"276_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","volume":"3","author":"V Ramappa","year":"2013","unstructured":"Ramappa V, Aithal GP (2013) Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol. 3(1):37\u201349","journal-title":"J Clin Exp Hepatol."},{"key":"276_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jctube.2015.09.001","volume":"1","author":"A Beebe","year":"2015","unstructured":"Beebe A, Seaworth B, Patil N (2015) Rifampicin-induced nephrotoxicity in a tuberculosis patient. J Clin Tuberc Other Mycobact Dis 1:13\u201315","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"276_CR6","volume-title":"Success rates for experimental drugs falls: study","author":"B Berkrot","year":"2011","unstructured":"Berkrot B (2011) Success rates for experimental drugs falls: study. Thomson Reuters, Toronto"},{"issue":"1","key":"276_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov. 6(1):29\u201340","journal-title":"Nat Rev Drug Discov."},{"key":"276_CR8","volume-title":"knowledge-based drug repositioningto drive R&D productivity","author":"R Thomson","year":"2012","unstructured":"Thomson R (2012) knowledge-based drug repositioningto drive R&D productivity. Thompson Reuters, Toronto"},{"key":"276_CR9","volume-title":"Old drugs, new life","author":"R Kerber","year":"2003","unstructured":"Kerber R (2003) Old drugs, new life. The Boston Globe, Boston"},{"key":"276_CR10","doi-asserted-by":"crossref","unstructured":"Konemann S, Dorr M, Felix SB (2017) Cardiac immunomodulation. In: Nusinovitch U (ed) The heart in rheumatic, autoimmune and inflammatory diseases. pp 681\u2013714","DOI":"10.1016\/B978-0-12-803267-1.00028-4"},{"issue":"2","key":"276_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jac\/dks405","volume":"68","author":"JC Palomino","year":"2013","unstructured":"Palomino JC, Martin A (2013) Is repositioning of drugs a viable alternative in the treatment of tuberculosis? J Antimicrob Chemother 68(2):275\u2013283","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"276_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"A Zumla","year":"2013","unstructured":"Zumla A, Nahid P, Cole ST (2013) Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 12(5):388\u2013404","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"276_CR13","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1128\/AAC.00753-13","volume":"57","author":"MW Carroll","year":"2013","unstructured":"Carroll MW, Jeon D, Mountz JM, Lee JD, Jeong YJ, Zia N et al (2013) Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis. Antimicrob Agents Chemother 57(8):3903\u20133909","journal-title":"Antimicrob Agents Chemother"},{"key":"276_CR14","first-page":"34293","volume":"6","author":"S Ram\u00f3n-Garc\u00eda","year":"2016","unstructured":"Ram\u00f3n-Garc\u00eda S, Gonz\u00e1lez del R\u00edo R, Villarejo AS, Sweet GD, Cunningham F, Barros D et al (2016) Repurposing clinically approved cephalosporins for tuberculosis therapy. 6:34293","journal-title":"Repurposing clinically approved cephalosporins for tuberculosis therapy."},{"issue":"12","key":"276_CR15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1586\/14737175.7.12.1649","volume":"7","author":"J Leegwater-Kim","year":"2007","unstructured":"Leegwater-Kim J, Waters C (2007) Role of tolcapone in the treatment of Parkinson\u2019s disease. Expert Rev Neurother 7(12):1649\u20131657","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"276_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/bmb\/ldw019","volume":"118","author":"A Maitra","year":"2016","unstructured":"Maitra A, Bates S, Shaik M, Evangelopoulos D, Abubakar I, McHugh TD et al (2016) Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs. Br Med Bull 118(1):138\u2013148","journal-title":"Br Med Bull"},{"issue":"2","key":"276_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/emmm.201201772","volume":"6","author":"B Lechartier","year":"2014","unstructured":"Lechartier B, Rybniker J, Zumla A, Cole ST (2014) Tuberculosis drug discovery in the post-post-genomic era. EMBO Mol Med 6(2):158\u2013168","journal-title":"EMBO Mol Med"},{"issue":"8","key":"276_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.6026\/97320630012368","volume":"12","author":"S Brindha","year":"2016","unstructured":"Brindha S, Sundaramurthi JC, Velmurugan D, Vincent S, Gnanadoss JJ (2016) Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB. Bioinformation 12(8):359\u2013367","journal-title":"Bioinformation"},{"key":"276_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mehy.2017.04.005","volume":"103","author":"S Brindha","year":"2017","unstructured":"Brindha S, Vincent S, Velmurugan D, Ananthakrishnan D, Sundaramurthi JC, Gnanadoss JJ (2017) Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosis. Med Hypotheses 103:39\u201345","journal-title":"Med Hypotheses"},{"issue":"11","key":"276_CR20","doi-asserted-by":"publisher","first-page":"e1000976","DOI":"10.1371\/journal.pcbi.1000976","volume":"6","author":"SL Kinnings","year":"2010","unstructured":"Kinnings SL, Xie L, Fung KH, Jackson RM, Xie L, Bourne PE (2010) The Mycobacterium tuberculosis drugome and its polypharmacological implications. PLoS Comput Biol 6(11):e1000976","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"276_CR21","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1039\/C5MB00476D","volume":"11","author":"G Ramakrishnan","year":"2015","unstructured":"Ramakrishnan G, Chandra NR, Srinivasan N (2015) Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv. Mol BioSyst 11(12):3316\u20133331","journal-title":"Mol BioSyst"},{"issue":"12","key":"276_CR22","doi-asserted-by":"publisher","first-page":"i246","DOI":"10.1093\/bioinformatics\/btq176","volume":"26","author":"Y Yamanishi","year":"2010","unstructured":"Yamanishi Y, Kotera M, Kanehisa M, Goto S (2010) Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26(12):i246\u2013i254","journal-title":"Bioinformatics"},{"key":"276_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-015-0089-z","volume":"7","author":"A Seal","year":"2015","unstructured":"Seal A, Ahn YY, Wild DJ (2015) Optimizing drug-target interaction prediction based on random walk on heterogeneous networks. J Cheminform 7:40","journal-title":"J Cheminform"},{"key":"276_CR24","doi-asserted-by":"publisher","first-page":"17417","DOI":"10.1038\/srep17417","volume":"5","author":"Z Isik","year":"2015","unstructured":"Isik Z, Baldow C, Cannistraci CV, Schroeder M (2015) Drug target prioritization by perturbed gene expression and network information. Sci Rep 5:17417","journal-title":"Sci Rep"},{"issue":"5","key":"276_CR25","doi-asserted-by":"publisher","first-page":"e1002503","DOI":"10.1371\/journal.pcbi.1002503","volume":"8","author":"F Cheng","year":"2012","unstructured":"Cheng F, Liu C, Jiang J, Lu W, Li W, Liu G et al (2012) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 8(5):e1002503","journal-title":"PLoS Comput Biol"},{"issue":"4 Pt 2","key":"276_CR26","doi-asserted-by":"publisher","first-page":"046115","DOI":"10.1103\/PhysRevE.76.046115","volume":"76","author":"T Zhou","year":"2007","unstructured":"Zhou T, Ren J, Medo M, Zhang YC (2007) Bipartite network projection and personal recommendation. Phys Rev E: Stat, Nonlin, Soft Matter Phys 76(4 Pt 2):046115","journal-title":"Phys Rev E: Stat, Nonlin, Soft Matter Phys"},{"issue":"4","key":"276_CR27","first-page":"361","volume":"46","author":"ZR Guo","year":"2011","unstructured":"Guo ZR (2011) Drug promiscuity. Yao Xue Xue Bao 46(4):361\u2013369","journal-title":"Yao Xue Xue Bao"},{"issue":"D1","key":"276_CR28","doi-asserted-by":"publisher","first-page":"Database issue","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y et al (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42(D1):Database issue\u2013Database issue1097","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"276_CR29","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2011","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A et al (2011) DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs. Nucleic Acids Res 39(Database issue):D1035\u2013D1041","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"276_CR30","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36(D1):D901\u2013D906","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"276_CR31","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P et al (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(Database issue):D668\u2013D672","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"276_CR32","doi-asserted-by":"publisher","first-page":"D1057","DOI":"10.1093\/nar\/gku1113","volume":"43","author":"RP Huntley","year":"2015","unstructured":"Huntley RP, Sawford T, Mutowo-Meullenet P, Shypitsyna A, Bonilla C, Martin MJ et al (2015) The GOA database: gene ontology annotation updates for 2015. Nucleic Acids Res 43(D1):D1057\u2013D1063","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"276_CR33","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1093\/bioinformatics\/btp536","volume":"25","author":"D Binns","year":"2009","unstructured":"Binns D, Dimmer E, Huntley R, Barrell D, O\u2019Donovan C, Apweiler R (2009) QuickGO: a web-based tool for gene ontology searching. Bioinformatics 25(22):3045\u20133046","journal-title":"Bioinformatics"},{"issue":"2","key":"276_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jmb.2004.06.028","volume":"341","author":"S Chan","year":"2004","unstructured":"Chan S, Segelke B, Lekin T, Krupka H, Cho US, Kim MY et al (2004) Crystal structure of the Mycobacterium tuberculosis dUTPase: insights into the catalytic mechanism. J Mol Biol 341(2):503\u2013517","journal-title":"J Mol Biol"},{"issue":"14","key":"276_CR35","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1128\/AEM.02880-10","volume":"77","author":"P Carroll","year":"2011","unstructured":"Carroll P, Faray-Kele MC, Parish T (2011) Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach. Appl Environ Microbiol 77(14):5040\u20135043","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"276_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/bies.10114","volume":"24","author":"A Bermingham","year":"2002","unstructured":"Bermingham A, Derrick JP (2002) The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. BioEssays 24(7):637\u2013648","journal-title":"BioEssays"},{"issue":"5","key":"276_CR37","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1006\/jmbi.2000.4094","volume":"302","author":"AM Baca","year":"2000","unstructured":"Baca AM, Sirawaraporn R, Turley S, Sirawaraporn W, Hol WG (2000) Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action. J Mol Biol 302(5):1193\u20131212","journal-title":"J Mol Biol"},{"issue":"9","key":"276_CR38","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.4014\/jmb.1503.03053","volume":"25","author":"T Liu","year":"2015","unstructured":"Liu T, Wang B, Guo J, Zhou Y, Julius M, Njire M et al (2015) Role of folP1 and folP2 genes in the action of sulfamethoxazole and trimethoprim against mycobacteria. J Microbiol Biotechnol 25(9):1559\u20131567","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"276_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1054\/drup.2000.0146","volume":"3","author":"O Skold","year":"2000","unstructured":"Skold O (2000) Sulfonamide resistance: mechanisms and trends. Drug Resist Updat 3(3):155\u2013160","journal-title":"Drug Resist Updat"},{"issue":"11","key":"276_CR40","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.4155\/fmc.13.97","volume":"5","author":"DI Hammoudeh","year":"2013","unstructured":"Hammoudeh DI, Zhao Y, White SW, Lee RE (2013) Replacing sulfa drugs with novel DHPS inhibitors. Future Med Chem 5(11):1331\u20131340","journal-title":"Future Med Chem"},{"issue":"1","key":"276_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1021\/jm900861d","volume":"53","author":"KE Hevener","year":"2010","unstructured":"Hevener KE, Yun MK, Qi J, Kerr ID, Babaoglu K, Hurdle JG et al (2010) Structural studies of pterin-based inhibitors of dihydropteroate synthase. J Med Chem 53(1):166\u2013177","journal-title":"J Med Chem"},{"issue":"5","key":"276_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/cmdc.201200049","volume":"7","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Hammoudeh D, Yun MK, Qi J, White SW, Lee RE (2012) Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity. ChemMedChem 7(5):861\u2013870","journal-title":"ChemMedChem"},{"issue":"9","key":"276_CR43","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2174\/092986711795029555","volume":"18","author":"AD Villela","year":"2011","unstructured":"Villela AD, Sanchez-Quitian ZA, Ducati RG, Santos DS, Basso LA (2011) Pyrimidine salvage pathway in Mycobacterium tuberculosis. Curr Med Chem 18(9):1286\u20131298","journal-title":"Curr Med Chem"},{"issue":"18","key":"276_CR44","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1016\/S0960-894X(03)00643-7","volume":"13","author":"V Vanheusden","year":"2003","unstructured":"Vanheusden V, Van Rompaey P, Munier-Lehmann H, Pochet S, Herdewijn P, Van Calenbergh S (2003) Thymidine and thymidine-5\u2032-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Bioorg Med Chem Lett 13(18):3045\u20133048","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"276_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","volume":"48","author":"CM Sassetti","year":"2003","unstructured":"Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48(1):77\u201384","journal-title":"Mol Microbiol"},{"issue":"1","key":"276_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1021\/ar800114w","volume":"42","author":"BG Vertessy","year":"2009","unstructured":"Vertessy BG, Toth J (2009) Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases. Acc Chem Res 42(1):97\u2013106","journal-title":"Acc Chem Res"},{"issue":"3","key":"276_CR47","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1128\/jb.170.3.1069-1075.1988","volume":"170","author":"HH El-Hajj","year":"1988","unstructured":"El-Hajj HH, Zhang H, Weiss B (1988) Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J Bacteriol. 170(3):1069\u20131075","journal-title":"J Bacteriol."},{"issue":"11","key":"276_CR48","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1002\/j.1460-2075.1993.tb06127.x","volume":"12","author":"MH Gadsden","year":"1993","unstructured":"Gadsden MH, McIntosh EM, Game JC, Wilson PJ, Haynes RH (1993) dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae. EMBO J 12(11):4425\u20134431","journal-title":"EMBO J"},{"issue":"6","key":"276_CR49","doi-asserted-by":"publisher","first-page":"e5923","DOI":"10.1371\/journal.pone.0005923","volume":"4","author":"P Kaur","year":"2009","unstructured":"Kaur P, Agarwal S, Datta S (2009) Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. PLoS ONE 4(6):e5923","journal-title":"PLoS ONE"},{"key":"276_CR50","first-page":"1","volume":"6","author":"V Ramachandran","year":"2013","unstructured":"Ramachandran V, Singh R, Yang X, Tunduguru R, Mohapatra S, Khandelwal S et al (2013) Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target. Adv Appl Bioinform Chem 6:1\u201313","journal-title":"Adv Appl Bioinform Chem"},{"issue":"5","key":"276_CR51","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1128\/AAC.02293-13","volume":"58","author":"PA Black","year":"2014","unstructured":"Black PA, Warren RM, Louw GE, van Helden PD, Victor TC, Kana BD (2014) Energy metabolism and drug efflux in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58(5):2491\u20132503","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"276_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2958.2009.06625.x","volume":"72","author":"RK Dhiman","year":"2009","unstructured":"Dhiman RK, Mahapatra S, Slayden RA, Boyne ME, Lenaerts A, Hinshaw JC et al (2009) Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Mol Microbiol 72(1):85\u201397","journal-title":"Mol Microbiol"},{"issue":"4","key":"276_CR53","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1128\/AAC.46.4.1114-1116.2002","volume":"46","author":"M Braback","year":"2002","unstructured":"Braback M, Riesbeck K, Forsgren A (2002) Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother 46(4):1114\u20131116","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"276_CR54","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1128\/AAC.46.5.1319-1324.2002","volume":"46","author":"GM Eliopoulos","year":"2002","unstructured":"Eliopoulos GM, Wennersten CB (2002) Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci. Antimicrob Agents Chemother 46(5):1319\u20131324","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"276_CR55","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acsinfecdis.6b00150","volume":"2","author":"JC Evans","year":"2016","unstructured":"Evans JC, Trujillo C, Wang Z, Eoh H, Ehrt S, Schnappinger D et al (2016) Validation of CoaBC as a bactericidal target in the coenzyme a pathway of Mycobacterium tuberculosis. ACS Infect Dis. 2(12):958\u2013968","journal-title":"ACS Infect Dis."},{"issue":"269","key":"276_CR56","doi-asserted-by":"publisher","first-page":"269r3","DOI":"10.1126\/scitranslmed.3010597","volume":"7","author":"UH Manjunatha","year":"2015","unstructured":"Manjunatha UH, Rao SPS, Kondreddi RR, Noble CG, Camacho LR, Tan BH et al (2015) Direct inhibitors of InhA are active against Mycobacterium tuberculosis. Sci Transl Med. 7(269):269r3","journal-title":"Sci Transl Med."},{"issue":"W1","key":"276_CR57","doi-asserted-by":"publisher","first-page":"W44","DOI":"10.1093\/nar\/gki477","volume":"33","author":"C Alland","year":"2005","unstructured":"Alland C, Moreews F, Boens D, Carpentier M, Chiusa S, Lonquety M et al (2005) RPBS: a web resource for structural bioinformatics. Nucleic Acids Res. 33(W1):W44\u2013W49","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"276_CR58","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-018-0276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-018-0276-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-018-0276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T03:55:29Z","timestamp":1571370929000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-018-0276-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1186\/s13321-018-0276-9","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}